Priorities for building Australia's MedTech sector

Priorities for building Australia's MedTech sector

NSW
Mar 7
CEDA NSW/ACT is delighted to welcome MTPConnect Sue MacLeman, Managing Director and Chief Executive Officer, to the 2018 Trustee program.

Speakers

Sue MacLeman, Managing Director and CEO, MTP Connect

Event overview

This briefing is by invitation only to CEDA Trustees. Trustees are senior leaders nominated by CEDA member organisations. At CEDA boardroom briefings Trustees hear from an informed, expert guest speaker in a private, small group setting. Invitations to boardroom briefings are a valued benefit of CEDA membership. Chatham House Rule applies.

Meet the speaker

Sue MacLeman
Managing Director and CEO, MTP Connect

MTPConnect is a not-for-profit organisation aiming to accelerate the rate of growth of the medical technologies, biotechnologies and pharmaceuticals sector in Australia, formed as part of the Federal Government’s $250 million Industry Growth Centres Initiative.

Sue has more than 25 years experience as a pharmaceutical, biotechnology and medical technology executive with roles in corporate, medical, commercial and business development at Schering-Plough Corporation (now Merck), Amgen, Bristol-Myers Squibb and Mesoblast Ltd.

Sue has also served as CEO and Board member of several ASX and NASDAQ listed companies in the sector and is currently a non-executive director at Reproductive Health Sciences Ltd and Oventus Medical Ltd.

Hosting opportunity available:

If you are interested in hosting this Trustee lunch in your boardroom please contact the event coordinator by clicking Contact us above.